A phase I study of the combination of rituximab and ipilimumab in patients with relapsed/ refractory B-cell lymphoma

Joseph M. Tuscano, Emanual Maverakis, Susan Groshen, Denice Tsao-Wei, Guillaume Luxardi, Alexander A. Merleev, Anne Beaven, John F. DiPersio, Leslie Popplewell, Robert Chen, Mark Kirschbaum, Mark A. Schroeder, Edward M. Newman

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I study of the combination of rituximab and ipilimumab in patients with relapsed/ refractory B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences